TD Cowen: 'Risk/Reward for Bicara Therapeutics Inc (BCAX) into ASCO is Great'
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ: BCAX).The analyst commented: "Ficera's ASCO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
